The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis

Acta Diabetologica

Volumn 51, Issue 5, 2014, Pages 691-703

  Dong, Fang ^a   Yang, Guang ^a   Pan, Hong Wei ^a   Huang, Wei Huang ^a   Jing, Li Peng ^a   Liang, Wen Kai ^a   Zhang, Na ^a   Zhang, Bao Huan ^a   Wang, Man ^a   Liu, Yang ^a   Zhang, Li Ju ^a   Zhang, Si Heng ^a   Li, He ^a   Chen, Chuan ^a   Nie, Li Hong ^b   Jing, Chun Xia ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

CTLA 4; LADA; Meta analysis; Polymorphism; PTPN22; Systematic review

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PTPN22 PROTEIN, HUMAN;

AUTOIMMUNE DISEASE; BODY MASS; CTLA 4 GENE; DATA EXTRACTION; EVALUATION STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; PTPN22 GENE; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; YOUNG ADULT;

CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK FACTORS; YOUNG ADULT;

EID: 84919465034     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0613-z     Document Type: Review

References (57)

1. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42(2):359–362
2. Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48(11):2195–2199. doi:10.1007/s00125-005-1954-5
3. Rolandsson O, Palmer JP (2010) Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia 53(7):1250–1253. doi:10.1007/s00125-010-1713-0
4. Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 18(7):1050–1064
5. Schernthaner G, Hink S, Kopp HP, Muzyka B, Streit G, Kroiss A (2001) Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes). Exp Clin Endocrinol Diabetes 109(Suppl 2):S94–S108. doi:10.1055/s-2001-18573
6. Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68–S72
7. Ekholm E, Gottsater A, Dahlin LB, Sundkvist G (2012) No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol 49(1):57–62. doi:10.1007/s00592-011-0273-1
8. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes UK Prospective Diabetes Study Group. Lancet 350(9087):1288–1293
9. Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, Cilio CM, Groop L (2008) Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57(5):1433–1437. doi:10.2337/db07-0299
10. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase Lyp. Blood 93(6):2013–2024
11. Wang S, Dong H, Han J, Ho WT, Fu X, Zhao ZJ (2010) Identification of a variant form of tyrosine phosphatase LYP. BMC Mol Biol 11:78. doi:10.1186/1471-2199-11-78
12. Cloutier JF, Veillette A (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189(1):111–121
13. Cannons JL, Schwartzberg PL (2004) Fine-tuning lymphocyte regulation: what’s new with tyrosine kinases and phosphatases? Curr Opin Immunol 16(3):296–303. doi:10.1016/j.coi.2004.03.011
14. Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ (2009) The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid Off J Am Thyroid Assoc 19(2):143–148. doi:10.1089/thy.2008.0301
15. Dieude P, Teixeira VH, Pierlot C, Cornelis F, Petit-Teixeira E (2008) Testing for linkage and association with rheumatoid arthritis a ptpn22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population. Ann Rheum Dis 67(6):900–901. doi:10.1136/ard.2007.077180
16. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75(2):330–337. doi:10.1086/422827
17. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511. doi:10.1038/nature01621
18. Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS (1996) Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem 271(43):26762–26771
19. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (New York, NY) 270(5238):985–988
20. Kisand K, Uibo R (2012) LADA and T1D in Estonian population—two different genetic risk profiles. Gene 497(2):285–291. doi:10.1016/j.gene.2012.01.089
21. Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R (2008) The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 31(3):534–538. doi:10.2337/dc07-1457
22. Pettersen E, Skorpen F, Kvaloy K, Midthjell K, Grill V (2010) Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trondelag Health Study. Diabetes 59(1):302–310. doi:10.2337/db09-0923
23. Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W, Zhou Z (2011) High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clin Endocrinol 74(5):587–592. doi:10.1111/j.1365-2265.2011.03976.x
24. Okruszko A, Szepietowska B, Wawrusiewicz-Kurylonek N, Gorska M, Kretowski A, Szelachowska M (2012) HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes. Arch Med Sci 8(5):874–878. doi:10.5114/aoms.2012.31619
25. Liu F, Liu J, Zheng TS, Li Q, Wang C, Pan XP, Lu H, Zhao YW (2012) The -1123G > C variant of PTPN22 gene promoter is associated with latent autoimmune diabetes in adult Chinese Hans. Cell Biochem Biophys 62(2):273–279. doi:10.1007/s12013-011-9291-4
26. Haller K, Kisand K, Pisarev H, Salur L, Laisk T, Nemvalts V, Uibo R (2007) Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69(2):121–127. doi:10.1111/j.1399-0039.2006.00745.x
27. Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD (2005) Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38(4):277–281
28. Cosentino A, Gambelunghe G, Tortoioli C, Falorni A (2002) CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann N Y Acad Sci 958:337–340
29. Thakkinstian A, McKay GJ, McEvoy M, Chakravarthy U, Chakrabarti S, Silvestri G, Kaur I, Li X, Attia J (2011) Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173(12):1365–1379. doi:10.1093/aje/kwr025
30. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557
32. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
33. Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D (2003) HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73(4):720–735. doi:10.1086/378097
34. Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC (2005) Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc 53(6):935–942. doi:10.1111/j.1532-5415.2005.53301.x
35. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34(6):1319–1328. doi:10.1093/ije/dyi169
36. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin res ed) 315(7109):629–634
37. Egger M, Smith GD, Altman DG (2008) Systematic reviews in health care: meta-analysis in context, 2nd ed. doi:10.1002/9780470693926
38. Giza S, Goulas A, Gbandi E, Effraimidou S, Papadopoulou-Alataki E, Eboriadou M, Galli-Tsinopoulou A (2013) The role of PTPN22 C1858T gene polymorphism in diabetes mellitus type 1: first evaluation in Greek children and adolescents. BioMed res int 2013:721604. doi:10.1155/2013/721604
39. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Fichna P, Nowak J (2010) PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int J Immunogenet 37(5):367–372. doi:10.1111/j.1744-313X.2010.00935.x
40. Lavrikova E, Nikitin AG, Seregin IuA, Zil’berman LI, Tsitlidze NM, Kuraeva TL, Peterkova VA, Dedov II, Nosikov VV (2009) Association of the C1858T polymorphism of the PTPN22 gene with type 1 diabetes. Mol Biol 43(6):1040–1043
41. Philip B, Isabel W (2011) Association of cytotoxic T lymphocyte-associated antigen 4 gene single nucleotide polymorphism with type 1 diabetes mellitus in Madurai population of Southern India. Indian J Human Geneti 17(2):85–89. doi:10.4103/0971-6866.86189
42. Ei Wafai RJ, Chmaisse HN, Makki RF, Fakhoury H (2011) Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes. Saudi J Kidney Dis Transpl 22(2):273–281
43. Ahmedov G, Ahmedova L, Sedlakova P, Cinek O (2006) Genetic association of type 1 diabetes in an Azerbaijanian population: the HLA-DQ, -DRB1*04, the insulin gene, and CTLA4. Pediatric Diabetes 7(2):88–93. doi:10.1111/j.1399-543X.2006.00152.x
44. Alkhateeb A, Marzouka NA, Tashtoush R (2013) Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population. Endocrine. doi:10.1007/s12020-013-9908-z
45. Gianchecchi E, Palombi M, Fierabracci A (2013) The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmun Rev 12(7):717–725. doi:10.1016/j.autrev.2012.12.003
46. Spink C, Stege G, Tenbrock K, Harendza S (2013) The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases. Nephrol Dialysis Transpl 28(11):2800–2805. doi:10.1093/ndt/gft381
47. AlFadhli S (2013) Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity. Genet Test Mol Biomark 17(4):336–341. doi:10.1089/gtmb.2012.0391
48. Shi L, Wei Y, Xun W, Han D (2013) Meta-analysis of the correlation between PTPN22 gene polymorphisms and susceptibility to systemic lupus erythematosus. Asia-Pacific J Publ Health 25(4 Suppl):22S–29S. doi:10.1177/1010539513496268
49. Xuan C, Lun LM, Zhao JX, Wang HW, Zhu BZ, Yu S, Liu Z, He GW (2013) PTPN22 gene polymorphism (C1858T) is associated with susceptibility to type 1 diabetes: a meta-analysis of 19,495 cases and 25,341 controls. Ann Hum Genet 77(3):191–203. doi:10.1111/ahg.12016
50. Chen Z, Fei M, Fu D, Zhang L, Ma Y, Wang Y, Zhang F, Xia Q, Wang X (2013) Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Gene 516(2):263–270. doi:10.1016/j.gene.2012.12.030
51. Zhai JX, Zou LW, Zhang ZX, Fan WJ, Wang HY, Liu T, Ren Z, Dai RX, Ye D (2013) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Mol Biol Rep 40(9):5213–5223. doi:10.1007/s11033-012-2125-7
52. Mayer A, Fabien N, Gutowski MC, Dubois V, Gebuhrer L, Bienvenu J, Orgiazzi J, Madec AM (2007) Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults. Eur J Endocrinol 157(1):53–61. doi:10.1530/eje-07-0060
53. Roh MO, Jung CH, Kim BY, Mok JO, Kim CH (2013) The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea. Acta Diabetol 50(2):129–134. doi:10.1007/s00592-010-0228-y
54. Groop L, Tuomi T, Rowley M, Zimmet P, Mackay IR (2006) Latent autoimmune diabetes in adults (LADA)–more than a name. Diabetologia 49(9):1996–1998. doi:10.1007/s00125-006-0345-x
55. Jin P, Huang G, Lin J, Luo S, Zhou Z (2011) Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity. Acta Diabetol 48(2):149–155. doi:10.1007/s00592-010-0250-0
56. Huang G, Wang X, Li Z, Li H, Li X, Zhou Z (2012) Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol 49(5):327–331. doi:10.1007/s00592-010-0196-2
57. Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20(9):439–444. doi:10.1016/j.tig.2004.06.014